{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:12:42Z","timestamp":1791807162053,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Finnish Medical Foundation, Kuopio University Hospital (VTR grant)"},{"name":"Kuopio University Hospital Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00330-017-4786-z","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T14:09:02Z","timestamp":1489414142000},"page":"4002-4012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI"],"prefix":"10.1007","volume":"27","author":[{"given":"Auni","family":"Lindgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarit","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi","family":"Rautiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otso","family":"Arponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annukka","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri","family":"M\u00e4kinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"H\u00e4rm\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Matti","family":"Kosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Vanninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sallinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"4786_CR1","doi-asserted-by":"crossref","first-page":"vi24","DOI":"10.1093\/annonc\/mdt333","volume":"24","author":"JA Ledermann","year":"2013","unstructured":"Ledermann JA, Raja FA, Fotopoulou C et al (2013) Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24:vi24\u2013vi32","journal-title":"Ann Oncol"},{"key":"4786_CR2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Bois du","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E et al (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials. Cancer 115:1234\u20131244","journal-title":"Cancer"},{"key":"4786_CR3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363:943\u2013953","journal-title":"N Engl J Med"},{"key":"4786_CR4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/pgp.0b013e31804216a0","volume":"26","author":"MH Khouja","year":"2007","unstructured":"Khouja MH, Baekelandt M, Nesland JM, Holm R (2007) The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma. Int J Gynecol Pathol 26:418\u2013425","journal-title":"Int J Gynecol Pathol"},{"key":"4786_CR5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","volume":"273","author":"L Claesson-Welsh","year":"2013","unstructured":"Claesson-Welsh L, Welsh M (2013) VEGFA and tumour angiogenesis. J Intern Med 273:114\u2013127","journal-title":"J Intern Med"},{"key":"4786_CR6","first-page":"469","volume":"39","author":"M Shibuya","year":"2006","unstructured":"Shibuya M (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39:469\u2013478","journal-title":"J Biochem Mol Biol"},{"key":"4786_CR7","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/j.1460-2075.1996.tb00521.x","volume":"15","author":"V Joukov","year":"1996","unstructured":"Joukov V, Pajusola K, Kaipainen A et al (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:1751","journal-title":"EMBO J"},{"key":"4786_CR8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","volume":"95","author":"MG Achen","year":"1998","unstructured":"Achen MG, Jeltsch M, Kukk E et al (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A 95:548\u2013553","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4786_CR9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.10100751","volume":"258","author":"I Thomassin-Naggara","year":"2011","unstructured":"Thomassin-Naggara I, Toussaint I, Perrot N et al (2011) Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology 258:793\u2013803","journal-title":"Radiology"},{"key":"4786_CR10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00330-007-0732-9","volume":"18","author":"S Fujii","year":"2008","unstructured":"Fujii S, Matsusue E, Kanasaki Y et al (2008) Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 18:18\u201323","journal-title":"Eur Radiol"},{"key":"4786_CR11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ejrad.2015.01.005","volume":"84","author":"J-W Oh","year":"2015","unstructured":"Oh J-W, Rha SE, Oh SN et al (2015) Diffusion-weighted MRI of epithelial ovarian cancers: correlation of apparent diffusion coefficient values with histologic grade and surgical stage. Eur J Radiol 84:590\u2013595","journal-title":"Eur J Radiol"},{"key":"4786_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiol.11110175","volume":"263","author":"E Sala","year":"2012","unstructured":"Sala E, Kataoka MY, Priest AN et al (2012) Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. Radiology 263:149\u2013159","journal-title":"Radiology"},{"key":"4786_CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jmri.23721","volume":"37","author":"HA Vargas","year":"2013","unstructured":"Vargas HA, Barrett T, Sala E (2013) MRI of ovarian masses. J Magn Reson Imaging 37:265\u2013281","journal-title":"J Magn Reson Imaging"},{"key":"4786_CR14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1148\/rg.305105073","volume":"30","author":"S Kyriazi","year":"2010","unstructured":"Kyriazi S, Collins DJ, Morgan VA et al (2010) Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics 30:1269\u20131285","journal-title":"Radiographics"},{"key":"4786_CR15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiology.177.2.2217776","volume":"177","author":"TL Chenevert","year":"1990","unstructured":"Chenevert TL, Brunberg JA, Pipe JG (1990) Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 177:401\u2013405","journal-title":"Radiology"},{"key":"4786_CR16","first-page":"19928","volume":"8","author":"X Fan","year":"2015","unstructured":"Fan X, Zhang H, Meng S et al (2015) Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors. Int J Clin Exp Med 8:19928\u201319937","journal-title":"Int J Clin Exp Med"},{"key":"4786_CR17","doi-asserted-by":"crossref","first-page":"e0138702","DOI":"10.1371\/journal.pone.0138702","volume":"10","author":"O Arponen","year":"2015","unstructured":"Arponen O, Arponent O, Sudah M et al (2015) Diffusion-weighted imaging in 3.0 tesla breast MRI: diagnostic performance and tumor characterization using small subregions vs. whole tumor regions of interest. PLoS One 10:e0138702","journal-title":"PLoS One"},{"key":"4786_CR18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11255-013-0557-1","volume":"46","author":"H Bae","year":"2014","unstructured":"Bae H, Yoshida S, Matsuoka Y et al (2014) Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. Int Urol Nephrol 46:555\u2013561","journal-title":"Int Urol Nephrol"},{"key":"4786_CR19","doi-asserted-by":"crossref","first-page":"e0122516","DOI":"10.1371\/journal.pone.0122516","volume":"10","author":"S Rautiainen","year":"2015","unstructured":"Rautiainen S, K\u00f6n\u00f6nen M, Sironen R et al (2015) Preoperative axillary staging with 3.0-T breast MRI: clinical value of diffusion imaging and apparent diffusion coefficient. PLoS One 10:e0122516","journal-title":"PLoS One"},{"key":"4786_CR20","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","volume":"365","author":"RA Burger","year":"2011","unstructured":"Burger RA, Brady MF, Bookman MA et al (2011) Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 365:2473\u20132483","journal-title":"N Engl J Med"},{"key":"4786_CR21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/mt.2008.258","volume":"17","author":"H Sallinen","year":"2009","unstructured":"Sallinen H, Anttila M, Narvainen J et al (2009) Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice. Mol Ther 17:278\u2013284","journal-title":"Mol Ther"},{"key":"4786_CR22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1600-0463.2003.apm1111103.x","volume":"111","author":"HB Salvesen","year":"2003","unstructured":"Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA (2003) Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. APMIS 111:1011\u20131018","journal-title":"APMIS"},{"key":"4786_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1470-2045(09)70190-1","volume":"11","author":"VN Harry","year":"2010","unstructured":"Harry VN, Semple SI, Parkin DE, Gilbert FJ (2010) Use of new imaging techniques to predict tumour response to therapy. Lancet Oncol 11:92\u2013102","journal-title":"Lancet Oncol"},{"key":"4786_CR24","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7412.1000171","author":"L Tuppurainen","year":"2013","unstructured":"Tuppurainen L, Sallinen H, Hakkarainen H et al (2013) Functional MRI measurements to predict early adenoviral gene therapy response in ovarian cancer mouse model. J Genet Syndr Gene Ther. doi: 10.4172\/2157-7412.1000171","journal-title":"J Genet Syndr Gene Ther"},{"key":"4786_CR25","first-page":"305","volume":"25","author":"ML Friedlander","year":"1998","unstructured":"Friedlander ML (1998) Prognostic factors in ovarian cancer. Semin Oncol 25:305\u2013314","journal-title":"Semin Oncol"},{"key":"4786_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1148\/radiol.14140283","volume":"274","author":"N Mori","year":"2015","unstructured":"Mori N, Ota H, Mugikura S et al (2015) Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology 274:66\u201373","journal-title":"Radiology"},{"key":"4786_CR27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/1522-2586(200012)12:6<1014::AID-JMRI29>3.0.CO;2-T","volume":"12","author":"T Moteki","year":"2000","unstructured":"Moteki T, Ishizaka H (2000) Diffusion-weighted EPI of cystic ovarian lesions: evaluation of cystic contents using apparent diffusion coefficients. J Magn Reson Imaging 12:1014\u20131019","journal-title":"J Magn Reson Imaging"},{"key":"4786_CR28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00004728-200203000-00015","volume":"26","author":"M Katayama","year":"2002","unstructured":"Katayama M, Masui T, Kobayashi S et al (2002) Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients? J Comput Assist Tomogr 26:250\u2013256","journal-title":"J Comput Assist Tomogr"},{"key":"4786_CR29","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ejrad.2014.03.024","volume":"83","author":"M Micc\u00f2","year":"2014","unstructured":"Micc\u00f2 M, Vargas HA, Burger IA et al (2014) Combined pre-treatment MRI and 18F-FDG PET\/CT parameters as prognostic biomarkers in patients with cervical cancer. Eur J Radiol 83:1169\u20131176","journal-title":"Eur J Radiol"},{"key":"4786_CR30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5306\/wjco.v2.i6.272","volume":"2","author":"SF Martins","year":"2011","unstructured":"Martins SF, Reis RM, Rodrigues AM et al (2011) Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies. World J Clin Oncol 2:272\u2013280","journal-title":"World J Clin Oncol"},{"key":"4786_CR31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A","volume":"80","author":"PJ Paley","year":"1997","unstructured":"Paley PJ, Staskus KA, Gebhard K et al (1997) Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80:98\u2013106","journal-title":"Cancer"},{"key":"4786_CR32","first-page":"55","volume":"10","author":"SF Martins","year":"2013","unstructured":"Martins SF, Garcia EA, Luz MAM et al (2013) Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer. Cancer Genomics Proteomics 10:55\u201367","journal-title":"Cancer Genomics Proteomics"},{"key":"4786_CR33","first-page":"3001","volume":"23","author":"A Gadducci","year":"2003","unstructured":"Gadducci A, Viacava P, Cosio S et al (2003) Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma. Anticancer Res 23:3001\u20133008","journal-title":"Anticancer Res"},{"key":"4786_CR34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bjc.6600701","volume":"88","author":"Y Yokoyama","year":"2003","unstructured":"Yokoyama Y, Charnock-Jones DS, Licence D et al (2003) Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 88:237\u2013244","journal-title":"Br J Cancer"},{"key":"4786_CR35","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.mri.2016.04.009","volume":"34","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Liu J, Liu C et al (2016) Intravoxel incoherent motion diffusion weighted MRI of cervical cancer - correlated with tumor differentiation and perfusion. Magn Reson Imaging 34:1050\u20131056","journal-title":"Magn Reson Imaging"},{"key":"4786_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-4087-3","author":"GY Cho","year":"2015","unstructured":"Cho GY, Moy L, Kim SG et al (2015) Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors. Eur Radiol. doi: 10.1007\/s00330-015-4087-3","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-017-4786-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-4786-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-4786-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:25:20Z","timestamp":1568913920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-017-4786-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["4786"],"URL":"https:\/\/doi.org\/10.1007\/s00330-017-4786-z","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}